Minimal residual disease testing in gastrointestinal cancers: a US perspective

Ryne C Ramaker, John H Strickler

Open source

DOI
10.1093/gastro/goag111
Published
2026-01-20
Container
Gastroenterology Report
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/gastro/goag111,
  title = {Minimal residual disease testing in gastrointestinal cancers: a US perspective},
  author = {Ryne C Ramaker and John H Strickler},
  year = {2026},
  journal = {Gastroenterology Report},
  doi = {10.1093/gastro/goag111},
  url = {https://doi.org/10.1093/gastro/goag111}
}

RIS

TY  - JOUR
TI  - Minimal residual disease testing in gastrointestinal cancers: a US perspective
AU  - Ryne C Ramaker
AU  - John H Strickler
PY  - 2026
JO  - Gastroenterology Report
DO  - 10.1093/gastro/goag111
UR  - https://doi.org/10.1093/gastro/goag111
ER  - 

APA

Ramaker, R. C., & Strickler, J. H. (2026). Minimal residual disease testing in gastrointestinal cancers: a US perspective. Gastroenterology Report. https://doi.org/10.1093/gastro/goag111

Source records